Use of integrin antagonists to inhibit angiogenesis
    1.
    发明授权
    Use of integrin antagonists to inhibit angiogenesis 失效
    使用整联蛋白拮抗剂抑制血管发生

    公开(公告)号:US07074408B2

    公开(公告)日:2006-07-11

    申请号:US09792200

    申请日:2001-02-23

    IPC分类号: A61K35/00 A61K38/00

    摘要: The present invention provides methods and compositions for inhibiting the biological activity of integrins, for inhibiting endothelial cell migration. and for inhibiting angiogenesis. In particular, the invention provides compositions comprising ADAM disintegrin domains and methods for using said compositions. In preferred embodiments the methods and compositions of the invention are used to inhibit angiogenesis and to treat diseases or conditions mediated by angiogenesis.

    摘要翻译: 本发明提供用于抑制整联蛋白的生物学活性的方法和组合物,用于抑制内皮细胞迁移。 并用于抑制血管发生。 特别地,本发明提供包含ADAM去整合素结构域的组合物和使用所述组合物的方法。 在优选的实施方案中,本发明的方法和组合物用于抑制血管发生和治疗由血管发生介导的疾病或病症。